179 related articles for article (PubMed ID: 24002129)
1. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008.
Duong LM; Richardson LC
J Registry Manag; 2013; 40(2):59-64. PubMed ID: 24002129
[TBL] [Abstract][Full Text] [Related]
2. Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007.
Duong LM; McCarthy BJ; McLendon RE; Dolecek TA; Kruchko C; Douglas LL; Ajani UA
Cancer; 2012 Sep; 118(17):4220-7. PubMed ID: 22907705
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma as a second malignant neoplasm.
Hamre MR; Severson RK; Chuba P; Lucas DR; Thomas RL; Mott MP
Radiother Oncol; 2002 Dec; 65(3):153-7. PubMed ID: 12464443
[TBL] [Abstract][Full Text] [Related]
4. Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017.
Cole S; Gianferante DM; Zhu B; Mirabello L
Cancer; 2022 Jun; 128(11):2107-2118. PubMed ID: 35226758
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.
Rockberg J; Bach BA; Amelio J; Hernandez RK; Sobocki P; Engellau J; Bauer HC; Liede A
J Bone Joint Surg Am; 2015 Nov; 97(21):1756-66. PubMed ID: 26537163
[TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
Mirabello L; Troisi RJ; Savage SA
Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
[TBL] [Abstract][Full Text] [Related]
8. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
9. Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study.
Hsu S; Quattrone M; Ostrom Q; Ryken TC; Sloan AE; Barnholtz-Sloan JS
J Neurosurg Spine; 2011 Jun; 14(6):742-7. PubMed ID: 21395394
[TBL] [Abstract][Full Text] [Related]
10. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.
Mirabello L; Troisi RJ; Savage SA
Int J Cancer; 2009 Jul; 125(1):229-34. PubMed ID: 19330840
[TBL] [Abstract][Full Text] [Related]
11. The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years.
Gilsenan A; Harding A; Kellier-Steele N; Harris D; Midkiff K; Andrews E
Osteoporos Int; 2018 Oct; 29(10):2335-2343. PubMed ID: 29978254
[TBL] [Abstract][Full Text] [Related]
12. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
13. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
[TBL] [Abstract][Full Text] [Related]
14. Incidence and grading of cranio-facial osteosarcomas.
van den Berg H; Merks JH
Int J Oral Maxillofac Surg; 2014 Jan; 43(1):7-12. PubMed ID: 24035127
[TBL] [Abstract][Full Text] [Related]
15. Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).
Wingo PA; Jamison PM; Hiatt RA; Weir HK; Gargiullo PM; Hutton M; Lee NC; Hall HI
Cancer Causes Control; 2003 Mar; 14(2):175-93. PubMed ID: 12749723
[TBL] [Abstract][Full Text] [Related]
16. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
17. Primary malignant bone tumours in Western Australia, 1972-1996.
Blackwell JB; Threlfall TJ; McCaul KA
Pathology; 2005 Aug; 37(4):278-83. PubMed ID: 16194825
[TBL] [Abstract][Full Text] [Related]
18. Demographic determinants of survival in osteosarcoma.
Nathan SS; Healey JH
Ann Acad Med Singap; 2012 Sep; 41(9):390-9. PubMed ID: 23052433
[TBL] [Abstract][Full Text] [Related]
19. Increased survival of patients aged 0-29 years with osteosarcoma: A period analysis, 1984-2013.
Wu J; Sun H; Li J; Guo Y; Zhang K; Lang C; Zou C; Ma H
Cancer Med; 2018 Aug; 7(8):3652-3661. PubMed ID: 29992762
[TBL] [Abstract][Full Text] [Related]
20. Regional variation and challenges in estimating the incidence of giant cell tumor of bone.
Liede A; Bach BA; Stryker S; Hernandez RK; Sobocki P; Bennett B; Wong SS
J Bone Joint Surg Am; 2014 Dec; 96(23):1999-2007. PubMed ID: 25471915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
